PERNIX THERAPEUTICS HLDGS IN - COM (PTX)

CUSIP: 71426V108

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
33,248,729
Share change
-976,362
Total reported value
$196,814,740
Price per share
$5.92
Number of holders
110
Value change
-$37,565,600
Number of buys
80
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q2 2015

As of 30 Jun 2015, PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,248,729 shares. The largest 10 holders included Broadfin Capital, LLC, JANUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, Elk Creek Partners, LLC, venBio Select Advisor LLC, WALL STREET ASSOCIATES, RK Capital Management, LLC, BlackRock Institutional Trust Company, N.A., ORBIMED ADVISORS LLC, and PUTNAM INVESTMENTS LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.